Ann: June 2019 Quarterly Activities and Cashflow Reports, page-16

I heard Canopy Growth's Bruce Linton was forced to resigned already. His decision to invest in AusCann was probably part of his poor performance along many other things.

https://seekingalpha.com/article/4274736-canopy-growth-life-bruce-linton-will-different

Now that the speculation of good announcement is over. The capsules are promised to be at end of the year. I see no plan for trial. I feel that they (PCI pharma) still have problems with producing high quality capsules for cannabis product probably due to issues in micro-encapsulation technology acquired from some where else. AusCann claimed that the first batch has been produced by PCI pharma but they still look at the quality. It shows that AusCann probably has zero technology input into this process.

Don't know. But it's a pretty long wait till end of the year while this stock will drift. However, it's a great run for those entering at the 30s. They would have taken profit though.